Skovronsky Daniel 4
4 · ELI LILLY & Co · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Skovronsky Daniel
EVP, CS&PO & Pres. LRL
Transactions
- Award
Common Stock
2024-02-12$737.26/sh+12,910$9,518,027→ 123,738 total - Award
Restricted Stock Unit
2024-02-12+8,989→ 8,989 totalFrom: 2025-02-01Exp: 2025-02-01→ Common Stock (8,989 underlying)
Holdings
- 70,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.